Unlike in arterial ischemia, where NLRP3 changes suddenly minutes to hours after stroke onset, NLRP3 in CVT activates in a subacute fashion, evident at day 3, and maintained until day 7 after CVT, which is in parallel with the immune cell activation and infiltration (88, 94). The gene discussed is NLRP3; the disease is stroke disorder.